Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ACSL1 anticorps (AA 435-547) (Biotin)

Acsl1 Reactivité: Humain ELISA Hôte: Lapin Polyclonal Biotin
N° du produit ABIN7158504
  • Antigène Voir toutes ACSL1 (Acsl1) Anticorps
    ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
    Épitope
    • 12
    • 8
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 435-547
    Reactivité
    • 37
    • 18
    • 18
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 36
    • 1
    Lapin
    Clonalité
    • 36
    • 1
    Polyclonal
    Conjugué
    • 19
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ACSL1 est conjugé à/à la Biotin
    Application
    • 26
    • 18
    • 4
    • 3
    • 3
    • 2
    • 1
    ELISA
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Long-chain-fatty-acid--CoA ligase 1 protein (435-547AA)
    Isotype
    IgG
    Top Product
    Discover our top product Acsl1 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
    Autre désignation
    ACSL1 (Acsl1 Produits)
    Synonymes
    anticorps ACS1, anticorps FACL1, anticorps FACL2, anticorps LACS, anticorps LACS1, anticorps LACS2, anticorps Acas, anticorps Acas1, anticorps Acs, anticorps FACS, anticorps Facl2, anticorps ACS, anticorps COAA, anticorps zgc:110081, anticorps CER8, anticorps ECERIFERUM 8, anticorps LONG-CHAIN ACYL-COA SYNTHASE 1, anticorps T8I13.8, anticorps F13F21.14, anticorps F13F21_14, anticorps LATERAL ROOT DEVELOPMENT 2, anticorps LRD2, anticorps long-chain acyl-CoA synthetase 2, anticorps acyl-CoA synthetase long chain family member 1, anticorps acyl-CoA synthetase long-chain family member 1, anticorps acyl-CoA synthetase long chain family member 1a, anticorps AMP-dependent synthetase and ligase family protein, anticorps long-chain acyl-CoA synthetase 2, anticorps ACSL1, anticorps Acsl1, anticorps acsl1a, anticorps LACS1, anticorps LACS2
    Sujet

    Background: Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses palmitoleate, oleate and linoleate.

    Aliases: ACS 1 antibody, ACS1 antibody, ACSL 1 antibody, ACSL1 antibody, ACSL1_HUMAN antibody, Acyl CoA synthetase 1 antibody, Acyl CoA synthetase long chain family member 1 antibody, Acyl-CoA synthetase 1 antibody, FACL 1 antibody, FACL 2 antibody, FACL1 antibody, FACL2 antibody, Fatty acid Coenzyme A ligase long chain 1 antibody, Fatty acid Coenzyme A ligase long chain 2 antibody, LACS 1 antibody, LACS 2 antibody, LACS antibody, LACS1 antibody, LACS2 antibody, Lignoceroyl CoA synthase antibody, Long chain acyl CoA synthetase 1 antibody, Long chain acyl CoA synthetase 2 antibody, Long chain fatty acid CoA ligase 1 antibody, Long chain fatty acid CoA ligase 2 antibody, Long chain fatty acid coenzyme A ligase 1 antibody, Long-chain acyl-CoA synthetase 1 antibody, Long-chain acyl-CoA synthetase 2 antibody, Long-chain fatty acid-CoA ligase 2 antibody, Long-chain-fatty-acid--CoA ligase 1 antibody, Palmitoyl CoA ligase 1 antibody, Palmitoyl CoA ligase 2 antibody, Palmitoyl-CoA ligase 1 antibody, Palmitoyl-CoA ligase 2 antibody, Paltimoyl CoA ligase 1 antibody

    UniProt
    P33121
    Pathways
    Regulation of Lipid Metabolism by PPARalpha
Vous êtes ici: